Curated patent data, including manually-written abstracts and value-added data (action, indication, technology), linked to companies, drugs, compounds and scientific literature.

Understand the pharma patent landscape

Analyze the most recent patent publications in a specific disease area to inform your R&D decisions
Determine which companies are active in a particular therapeutic or technology area
Evaluate competitors’ patent portfolios and the legal status of key patents
Understand how a patent family has evolved over time

Enhanced patent data for insights you can trust

Comprehensive coverage
Make decisions with confidence using patent data from wide range of sources such as WIPO, PCT, WILA, EP, US patents, INPADOC SPC, Orange Book, and 105 global patent offices
Manually-written abstracts
Quickly understand a patent family’s claims using abstracts written by the Clarivate editorial team that clearly describe the compound’s novelty, use and advantage
Value-added data
Navigate patents with ease using editorially-enhanced data assigned to each patent family, including the action, indication, technology, legal status and expiration date
Linked structures
See the complete picture with up to 999 chemical structures extracted from the claims and listed for each patent
Easily integrated
Access data via an API or a data feed